🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Status
Completed
Location
AMCR Institute, Inc.
Start Date
2015-06-30
Trial ID
NCT02414958
Treatments Being Tested
the aim of this study is to examine the role of autonomic nervous system in...
Status
Completed
Location
Diabetes Division, UTHSCSA
Start Date
2018-05-20
Trial ID
NCT03193684
Treatments Being Tested
This study is open to adults with chronic heart failure (HF) who have a red...
Status
Recruiting
Location
Cure Clinical Research
Start Date
2025-05-20
Trial ID
NCT06935370
Treatments Being Tested
Double-blind, parallel arm, randomized controlled trial, in which non-lacta...
Status
Completed
Location
Leadership Sinai Centre foe Diabetes - Mount Sinai Hospital
Start Date
2018-07-01
Trial ID
NCT03215069
Treatments Being Tested
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
Patients with type 2 diabetes mellitus are exposed to an excessive heart fa...
Status
Terminated
Location
Hannover Medical School
Start Date
2016-04-27
Trial ID
NCT02728453
Treatments Being Tested
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
Start Date
2025-04
Trial ID
NCT06894784
In this multicenter, randomized, placebo-controlled trial in pre-heat failu...
Status
Recruiting
Location
Fuwai Hospital, Chinese Academy of Medical Sciences
Start Date
2024-01-19
Trial ID
NCT06055452
Treatments Being Tested
The aim of this study is to investigate the efficacy and safety of two dose...
Status
Completed
Location
1276.10.11036 Boehringer Ingelheim Investigational Site
Start Date
2012-10
Trial ID
NCT01649297
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001